Henderson et al. [83] showed that volatile organic compounds can be used as a non-invasive measure of inflammation in IBD patients during prolonged moderate-intensity walking, with butanoic acid levels significantly correlating with plasma IL-6. Here, IL6 is linked to inflammatory bowel disease.